Glenmark Pharmaceuticals ltd — Capital/Financing Update 2021

Jul 20, 2021

July 20, 2021

To, Dy. General Manager Department of Corporate Services, BSE Ltd. Phiroze Jeejeeboy Towers Dalal Street, Fort Mumbai - 400001 Ref: Scrip Code No: 532296

To,

The Manager-Listing National Stock Exchange of India Ltd., Plot No. C/1, G Block, Bandra Kurla Complex (BKC) Bandra (east) Mumbai - 400051 Ref: Scrip Name: GLENMARK

Dear Sirs/Madam,

Sub: Filing and approval of the Red Herring Prospectus ("RHP") dated July 19, 2021 of our wholly owned subsidiary "Glenmark Life Sciences Limited" in connection with its proposed initial public offering of equity shares ("Offer" or "IPO")

Further to our intimation dated April 16, 2021 regarding submission of the draft red herring prospectus dated April 16, 2021 ("DRHP") with the Securities and Exchange Board of India, by our wholly owned subsidiary, Glenmark Life Sciences Limited, please be informed that on July 19, 2021, Glenmark Life Sciences Limited had filed the RHP with the Registrar of Companies, Pune at Maharashtra ("ROC") in connection with the Offer. The RHP has been taken on record by the ROC on July 20, 2021.

The details and timelines for the proposed Offer are as under:

Fresh Issue	Up to ~10,600 million
forGlenmarkOfferSalebyPharmaceuticals Limited	Up to 6,300,000 Equity Shares
Anchor investor Bid / Offer period	One working day prior to the Bid / Offer openingdate i.e. July 26, 2021
Bid/Offer Opening Date	July 27, 2021
Bid/ Offer Closing Date	July 29, 2021
Expected Date of Listing	August 6, 2021

This is for your kind information and record .

Thanking you,

Yours faithfully, For ~rmace MU

Harish K Company Secretary and Comp Tel: 4018 9999 / 4018 9879 Fax: 4018 9986 (Legal & Secretarial Dept.) icer

Glenmark Pharmaceuticals Ltd.